Emerging Evidence: Long-term oral anticoagulation following provoked VTE? A focus on the HI-PRO Trial.

Updated description: 
This webinar will review findings from the recent HI-PRO Trial on the use of apixaban for extended treatment of provoked venous thromboembolism (VTE). Faculty will discuss the trial design, results, clinical implications, patient selection, and how this evidence may influence real-world management of provoked VTE.

Updated Speakers:

Arthur Allen, PharmD, CACP
VA Salt Lake City Health Care System

Margaret Fang, MD, MPH
University of California, San Francisco (UCSF)

Gregory Piazza, MD, MS
Brigham and Women’s Hospital

Naomi Yates, PharmD, BCACP
Kaiser Permanente Georgia